Welcome to LookChem.com Sign In|Join Free

CAS

  • or
1,4-Cyclohexanediamine, N,N-bis(phenylmethyl)-, trans- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

755039-81-7 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 755039-81-7 Structure
  • Basic information

    1. Product Name: 1,4-Cyclohexanediamine, N,N-bis(phenylmethyl)-, trans-
    2. Synonyms:
    3. CAS NO:755039-81-7
    4. Molecular Formula: C20H26N2
    5. Molecular Weight: 294.44
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 755039-81-7.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: 1,4-Cyclohexanediamine, N,N-bis(phenylmethyl)-, trans-(CAS DataBase Reference)
    10. NIST Chemistry Reference: 1,4-Cyclohexanediamine, N,N-bis(phenylmethyl)-, trans-(755039-81-7)
    11. EPA Substance Registry System: 1,4-Cyclohexanediamine, N,N-bis(phenylmethyl)-, trans-(755039-81-7)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 755039-81-7(Hazardous Substances Data)

755039-81-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 755039-81-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,5,5,0,3 and 9 respectively; the second part has 2 digits, 8 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 755039-81:
(8*7)+(7*5)+(6*5)+(5*0)+(4*3)+(3*9)+(2*8)+(1*1)=177
177 % 10 = 7
So 755039-81-7 is a valid CAS Registry Number.

755039-81-7Relevant articles and documents

Inhibitors of JNK

-

Page/Page column 34, (2011/02/26)

The invention relates to JNK inhibitors and corresponding methods, formulations, and compositions for inhibiting JNK and treating JNK-mediated disorders. The application discloses JNK inhibitors, as described below in Formula I: wherein p, q, Y′, r, Rsup

Storage stable perfusion solution for dihydropteridinones

-

Page/Page column 19, (2008/06/13)

Disclosed are storage stable aqueous infusible or injectable solutions containing an active substance of general formula (I) wherein the groups L, R1, R2, R3, R4 and R5 have the meanings given in the claims and in the specification, and an amount of a physiologically acceptable acid or mixture of acids sufficient to dissolve the active substance and act as a stabiliser, optionally together with other formulating excipients suitable for parenteral administration, and a process for preparing the infusible or injectable solutions according to the invention.

DIHYDROPTERIDINONES, METHOD FOR THE PRODUCTION AND USE THEREOF IN THE FORM OF DRUGS

-

Page/Page column 43, (2010/02/08)

The invention relates to novel dihydropteridinones of general formula (I), wherein rests L, R1-R5 have the significance indicated in claims and a specification, in the isomers thereof, in a method for producing and using said dihydropteridinones in the form of drugs.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 755039-81-7